letrozole has been researched along with Choriocarcinoma in 2 studies
Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Long, BJ | 1 |
Tilghman, SL | 1 |
Yue, W | 1 |
Thiantanawat, A | 1 |
Grigoryev, DN | 1 |
Brodie, AM | 1 |
Mor, G | 1 |
Eliza, M | 1 |
Song, J | 1 |
Wiita, B | 1 |
Chen, S | 1 |
Naftolin, F | 1 |
2 other studies available for letrozole and Choriocarcinoma
Article | Year |
---|---|
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
Topics: Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell | 1998 |
17alpha-methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture.
Topics: Aromatase; Aromatase Inhibitors; Binding, Competitive; Cell Line; Choriocarcinoma; Dose-Response Rel | 2001 |